Grove Bank & Trust’s NeoGenomics NEO Stock Holding History

Grove Bank & Trust’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.92K	Buy	+200	New	+$1.93K	﹤0.01%	781

Other funds holding NEO

MFG Wealth Management Indianapolis, Indiana $140M AUM 44.72% 1-Year Est. Return

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

Holos Integrated Wealth Kennett Square, Pennsylvania $214M AUM 14.99% 1-Year Est. Return

Burkett Financial Services Rock Hill, South Carolina $320M AUM 19.24% 1-Year Est. Return

Beaird Harris Wealth Management Dallas, Texas $1.6B AUM 16.64% 1-Year Est. Return

Grove Bank & Trust's NEO Position: Q2 2026 in Review

Grove Bank & Trust opened a new position in NeoGenomics (NEO) in Q2 2026: 200 shares worth $2.92K. The stake represents ﹤0.01% of the portfolio and ranks #781 among its holdings.

24 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Grove Bank & Trust held 200 shares of NeoGenomics worth $2.92K as of Q2 2026.
NeoGenomics was a new Grove Bank & Trust position in Q2 2026.
NeoGenomics made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #781 holding.
24 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.